NEWARK, Calif., June 15, 2018 /PRNewswire/ -- The Board of Directors of Theranos, Inc., announced today that Elizabeth Holmes has stepped down as Chief Executive Officer and David Taylor, the Company's General Counsel, has been appointed Chief Executive Officer and General Counsel.
Ms. Holmes remains with the Company as
View original content:http://www.prnewswire.com/news-releases/theranos-announces-management-transition-300667225.html
SOURCE Theranos, Inc.
Subscribe to our Free Newsletters!
Complex regional pain syndrome (CRPS) is rare chronic pain disorder usually involving an arm or ...
Polyarthritis refers to pain in four or more joints simultaneously due to various causes ranging ...
Gardner or Gardner''s syndrome, also known as familial adenomatous polyposis (FAP), is an autosomal ...View All